Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

- Asthma
- Completed

Study Title: Chronic-dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics

Teva Identifier: IXR-303-25-167

ClinicalTrials.gov Identifier: NCT00308685

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol 90mcg | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 4 Years to 11 Years

Trial Duration: 07/01/2007 - 01/00/1900

Phase: Phase 3

Study Type

Interventional